Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study

OBJECTIVES: Animal and ex vitro studies suggested lipid-lowering agents (LLAs) may be used as an adjunct to standard anti- tuberculosis (TB) treatment. No human study has been conducted to date. Using the Taiwan National Health Insurance Research Database (NHIRD), the current population-based cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yung-Tai, Kuo, Shu-Chen, Chao, Pei-Wen, Chang, Yea-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329498/
https://www.ncbi.nlm.nih.gov/pubmed/30633771
http://dx.doi.org/10.1371/journal.pone.0210479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329498/
https://www.ncbi.nlm.nih.gov/pubmed/30633771
http://dx.doi.org/10.1371/journal.pone.0210479

Ejemplares similares